NU

NeuroMetrix

- NASDAQ:NURO
Last Updated 2024-03-26

LinkedIn Profile

Access NeuroMetrix historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:nuro 56402 Mar 23rd, 2024 12:00AM NeuroMetrix, Inc. 3.4K 63.00 Open Mar 23rd, 2024 12:00AM Mar 23rd, 2024 07:10PM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 22nd, 2024 12:00AM NeuroMetrix, Inc. 3.4K 63.00 Open Mar 21st, 2024 11:51PM Mar 22nd, 2024 06:58PM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 21st, 2024 12:00AM NeuroMetrix, Inc. 3.4K 63.00 Open Mar 21st, 2024 12:04AM Mar 21st, 2024 05:42PM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 20th, 2024 12:00AM NeuroMetrix, Inc. 3.4K 64.00 Open Mar 20th, 2024 12:45AM Mar 20th, 2024 07:43PM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 19th, 2024 12:00AM NeuroMetrix, Inc. 3.4K 64.00 Open Mar 18th, 2024 11:39PM Mar 19th, 2024 06:15PM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 18th, 2024 12:00AM NeuroMetrix, Inc. 3.4K 64.00 Open Mar 18th, 2024 12:01AM Mar 18th, 2024 07:27PM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 16th, 2024 12:00AM NeuroMetrix, Inc. 3.4K 64.00 Open Mar 15th, 2024 11:30PM Mar 16th, 2024 07:14PM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 15th, 2024 12:00AM NeuroMetrix, Inc. 3.4K 64.00 Open Mar 15th, 2024 01:17AM Mar 15th, 2024 09:04AM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 14th, 2024 12:00AM NeuroMetrix, Inc. 3.4K 64.00 Open Mar 13th, 2024 11:29PM Mar 14th, 2024 12:26PM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services
nasdaq:nuro 56402 Mar 13th, 2024 12:00AM NeuroMetrix, Inc. 3.4K 64.00 Open Mar 12th, 2024 11:24PM Mar 13th, 2024 10:56AM NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, and biomedical engineering Open 4b Gill St Woburn Massachusetts US 01801 NeuroMetrix Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.